Albuterol Sulfate Inhalation Inhalant
Product Images NDC 69238-1291
View Photos of Packaging, Regulatory Labels, and Product Appearance
Product Visual Gallery
This gallery contains 14 technical images submitted to the FDA as part of the official labeling for Albuterol Sulfate Inhalation (NDC 69238-1291). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.
As provided by Amneal Pharmaceuticals Ny Llc, these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.
Product Images & Figures Index
Figure I (Albuterol Sulfate Inhalation Proair 10)
Figure J (Albuterol Sulfate Inhalation Proair 11)
Figure K (Albuterol Sulfate Inhalation Proair 12)
Label (Albuterol Sulfate Inhalation Proair 13)
This text contains information about an inhalation medication called Albuterol Sulfate Acerosol. It is dispensed as 90 mcg per actuation for oral inhalation. The container holds 200 metered inhalations and has a net content of 8.5 grams. The contents include albuterol, propellant (HFA-134a), and ethanol. It warns not to exceed the prescribed dose and to seek medical attention if breathing difficulty persists. The product should be stored between 15°C and 30°C and shaken well before use. This medication is distributed by Amneal Pharmaceuticals LLC in Bridgewater, NJ and is made in Ireland. The package insert should be referred to for more detailed prescribing information.*
Carton (Albuterol Sulfate Inhalation Proair 14)
This text seems to be a detailed description of a medication called 'Albuterol Sulfate Inhalation Aerosol', providing information such as dosage instructions, caution to not exceed the recommended usage, details about the content of the canister, and guidance to seek medical attention if needed. The text also mentions the appropriate procedures for pharmacists, the manufacturer, and contact information for inquiries.*
Day 1 Figure (Albuterol Sulfate Inhalation Proair 2)
Day 43 Figure (Albuterol Sulfate Inhalation Proair 3)
This text provides information about a study comparing the effects of three different inhalation aerosols on the % change in Forced Expiratory Volume in one second (FEV1) over time in hours. The aerosols studied are O Abuterol Sulfate Inhalation Aerosol, Matched Placebo HFA Inhalation Aerosol, and Marketed HFA-134 Albuterol.*
Figure A And B (Albuterol Sulfate Inhalation Proair 4)
Figure C (Albuterol Sulfate Inhalation Proair 5)
Figure D (Albuterol Sulfate Inhalation Proair 6)
Figure E (Albuterol Sulfate Inhalation Proair 7)
Figure F (Albuterol Sulfate Inhalation Proair 8)
Figure G And H (Albuterol Sulfate Inhalation Proair 9)
This text appears to illustrate the importance of ensuring that a medication dispenser is not blocked to allow for the proper flow of medicine. It contrasts the consequences of the dispenser being blocked versus not being blocked. The figures labeled as Figure G and Figure H might visually represent this concept.*
* These product label images have been analyzed using experimental machine learning. Please verify findings with the primary label text.